RF
Rhonda Farnum (SVP, COMM & MEDICAL AFFAIRS) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in Theravance Biopharma, Inc. (TBPH). The largest single filing was $583K of TBPH (31,067 sh across 3 lots, as filed), executed Dec 3 2025. Data as of Nov 7 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
4
0 buys · 4 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$1.2M
shares × price, as filed
Last traded
Sep 15
Filed Sep 17
Median ADV $11.0M across their filed names
Open performance→Volume by month
Buys $0
Sells $1.5M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
4 filings
Sector per market data · by filing · past 12 months
Most traded names
TBPH
Theravance Biopharma, Inc.
TBPH · 0 buys · 5 sells
5 filings
Recent filings
TBPHSALE
Theravance Biopharma, Inc.
View filing →
$113K6,657 sh × $17.03
Exec Sep 15
Filed Sep 17 · 5:52 PM ET TBPHSALE Theravance Biopharma, Inc. View filing → $109K
6,657 sh × $16.39
Exec Jun 15
Filed Jun 17 · 5:30 PM ET TBPHSALE Theravance Biopharma, Inc. View filing → $434K
31,067 sh across 3 lots
Exec Mar 16
Filed Mar 18 · 5:30 PM ET TBPHSALE Theravance Biopharma, Inc. View filing → $583K
31,067 sh across 3 lots
Exec Dec 3 2025
Filed Dec 5 2025 · 5:30 PM ET TBPHSALE Theravance Biopharma, Inc. View filing → $264K
24,000 sh × $11.00
Exec Jun 2 2025
Filed Jun 4 2025 · 5:30 PM ET